Skip to content
Mahaz News
US
World
Business
Entertainment
Technology
Sports
Health
Search for:
Home
Respiratory Tract Cancer
Business
Sanofi suffers main blow as its cutting-edge most cancers drug disappoints in Phase III trials
Business
Amgen to proceed to hunt full approval of Lumakras most cancers drug after FDA panel votes in opposition to it
Business
Merck and Eisai say two lung-cancer trials failed to satisfy their major objectives
Business
Non-smoking lung most cancers is on the rise. Blame air pollution, says American Lung Association.